Transaction · 0001493152-25-000151

Patel Snehal

Patel Snehal, CC, reported an open-market or private purchase at Greenwich LifeSciences, Inc. involving 2400.000000 shares for an estimated $27264.00. Reported holdings after the transaction were 5541702.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCC

GLSIGreenwich LifeSciences, Inc.

Filing timeJan 03

Trade dateDec 31, 2024

Filing · SECView on SEC

InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

—

Pre-filing

1mo ago1w ago1d ago

Returns since

7d30d90d180d1y

GLSI price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

GLSI since 2025-01-03Filed 608 days ago · 30 days of pre-filing context shaded

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Buy
Identifier: 0001493152-25-000151
Transaction date: Dec 31, 2024
Shares: 2.40k sh
Estimated value: $2.72M
Holdings after: 5.54M sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M

Director Buy Direct Ownership 10% Owner Buy

+24score

Filing-only score

+24

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and CFO

Officer YesDirector Yes10% YesOther No

Footnotes & amended

No footnotes recorded.

Original filing · 0001493152-25-000151

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

GLSI